{"name":"Lars Wiuff Andersen","slug":"lars-wiuff-andersen","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Rare Disease","slug":"rare-disease","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Vasopressin, Arginine","genericName":"Vasopressin, Arginine","slug":"vasopressin-arginine","indication":"Variceal bleeding (esophageal varices)","status":"marketed"}]}],"pipeline":[{"name":"Vasopressin, Arginine","genericName":"Vasopressin, Arginine","slug":"vasopressin-arginine","phase":"marketed","mechanism":"Arginine vasopressin is a peptide hormone that binds to vasopressin receptors to increase blood pressure, promote water reabsorption in the kidneys, and enhance blood clotting.","indications":["Variceal bleeding (esophageal varices)","Diabetes insipidus","Hypotension/shock","Hemophilia A and von Willebrand disease"],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}